Nanomaterials in Personalized Medicine Market, Global Outlook and Forecast 2024-2031

Report ID: 1365180 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Nanomaterials in Personalized Medicine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nanomaterials in Personalized Medicine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nanomaterials in Personalized Medicine Overall Market Size
    2.1 Global Nanomaterials in Personalized Medicine Market Size: 2021 VS 2028
    2.2 Global Nanomaterials in Personalized Medicine Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Nanomaterials in Personalized Medicine Players in Global Market
    3.2 Top Global Nanomaterials in Personalized Medicine Companies Ranked by Revenue
    3.3 Global Nanomaterials in Personalized Medicine Revenue by Companies
    3.4 Top 3 and Top 5 Nanomaterials in Personalized Medicine Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Nanomaterials in Personalized Medicine Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Nanomaterials in Personalized Medicine Players in Global Market
        3.6.1 List of Global Tier 1 Nanomaterials in Personalized Medicine Companies
        3.6.2 List of Global Tier 2 and Tier 3 Nanomaterials in Personalized Medicine Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Nanomaterials in Personalized Medicine Market Size Markets, 2021 & 2028
        4.1.2 Nano-Medicine
        4.1.3 Nanometer Medical Instrument
        4.1.4 Others
    4.2 By Type - Global Nanomaterials in Personalized Medicine Revenue & Forecasts
        4.2.1 By Type - Global Nanomaterials in Personalized Medicine Revenue, 2017-2022
        4.2.2 By Type - Global Nanomaterials in Personalized Medicine Revenue, 2023-2028
        4.2.3 By Type - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nanomaterials in Personalized Medicine Market Size, 2021 & 2028
        5.1.2 Anticancer
        5.1.3 CNS Products
        5.1.4 Anti-infection
        5.1.5 Others
    5.2 By Application - Global Nanomaterials in Personalized Medicine Revenue & Forecasts
        5.2.1 By Application - Global Nanomaterials in Personalized Medicine Revenue, 2017-2022
        5.2.2 By Application - Global Nanomaterials in Personalized Medicine Revenue, 2023-2028
        5.2.3 By Application - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Nanomaterials in Personalized Medicine Market Size, 2021 & 2028
    6.2 By Region - Global Nanomaterials in Personalized Medicine Revenue & Forecasts
        6.2.1 By Region - Global Nanomaterials in Personalized Medicine Revenue, 2017-2022
        6.2.2 By Region - Global Nanomaterials in Personalized Medicine Revenue, 2023-2028
        6.2.3 By Region - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Nanomaterials in Personalized Medicine Revenue, 2017-2028
        6.3.2 US Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.3.3 Canada Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.3.4 Mexico Nanomaterials in Personalized Medicine Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Nanomaterials in Personalized Medicine Revenue, 2017-2028
        6.4.2 Germany Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.3 France Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.4 U.K. Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.5 Italy Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.6 Russia Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.7 Nordic Countries Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.4.8 Benelux Nanomaterials in Personalized Medicine Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Nanomaterials in Personalized Medicine Revenue, 2017-2028
        6.5.2 China Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.5.3 Japan Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.5.4 South Korea Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.5.5 Southeast Asia Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.5.6 India Nanomaterials in Personalized Medicine Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Nanomaterials in Personalized Medicine Revenue, 2017-2028
        6.6.2 Brazil Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.6.3 Argentina Nanomaterials in Personalized Medicine Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Nanomaterials in Personalized Medicine Revenue, 2017-2028
        6.7.2 Turkey Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.7.3 Israel Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.7.4 Saudi Arabia Nanomaterials in Personalized Medicine Market Size, 2017-2028
        6.7.5 UAE Nanomaterials in Personalized Medicine Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Nanomaterials in Personalized Medicine Major Product Offerings
        7.1.4 Abbott Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Nanomaterials in Personalized Medicine Major Product Offerings
        7.2.4 Amgen Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 Biogen
        7.3.1 Biogen Corporate Summary
        7.3.2 Biogen Business Overview
        7.3.3 Biogen Nanomaterials in Personalized Medicine Major Product Offerings
        7.3.4 Biogen Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.3.5 Biogen Key News
    7.4 Celgene
        7.4.1 Celgene Corporate Summary
        7.4.2 Celgene Business Overview
        7.4.3 Celgene Nanomaterials in Personalized Medicine Major Product Offerings
        7.4.4 Celgene Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.4.5 Celgene Key News
    7.5 Gilead Sciences
        7.5.1 Gilead Sciences Corporate Summary
        7.5.2 Gilead Sciences Business Overview
        7.5.3 Gilead Sciences Nanomaterials in Personalized Medicine Major Product Offerings
        7.5.4 Gilead Sciences Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.5.5 Gilead Sciences Key News
    7.6 Merck and Co
        7.6.1 Merck and Co Corporate Summary
        7.6.2 Merck and Co Business Overview
        7.6.3 Merck and Co Nanomaterials in Personalized Medicine Major Product Offerings
        7.6.4 Merck and Co Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.6.5 Merck and Co Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Nanomaterials in Personalized Medicine Major Product Offerings
        7.7.4 Pfizer Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.7.5 Pfizer Key News
    7.8 Roche
        7.8.1 Roche Corporate Summary
        7.8.2 Roche Business Overview
        7.8.3 Roche Nanomaterials in Personalized Medicine Major Product Offerings
        7.8.4 Roche Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.8.5 Roche Key News
    7.9 Sanofi
        7.9.1 Sanofi Corporate Summary
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Nanomaterials in Personalized Medicine Major Product Offerings
        7.9.4 Sanofi Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.9.5 Sanofi Key News
    7.10 Stryker
        7.10.1 Stryker Corporate Summary
        7.10.2 Stryker Business Overview
        7.10.3 Stryker Nanomaterials in Personalized Medicine Major Product Offerings
        7.10.4 Stryker Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.10.5 Stryker Key News
    7.11 Teva Pharmaceuticals
        7.11.1 Teva Pharmaceuticals Corporate Summary
        7.11.2 Teva Pharmaceuticals Business Overview
        7.11.3 Teva Pharmaceuticals Nanomaterials in Personalized Medicine Major Product Offerings
        7.11.4 Teva Pharmaceuticals Nanomaterials in Personalized Medicine Revenue in Global Market (2017-2022)
        7.11.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Nanomaterials in Personalized Medicine Market Opportunities & Trends in Global Market
    Table 2. Nanomaterials in Personalized Medicine Market Drivers in Global Market
    Table 3. Nanomaterials in Personalized Medicine Market Restraints in Global Market
    Table 4. Key Players of Nanomaterials in Personalized Medicine in Global Market
    Table 5. Top Nanomaterials in Personalized Medicine Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Nanomaterials in Personalized Medicine Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Nanomaterials in Personalized Medicine Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Nanomaterials in Personalized Medicine Product Type
    Table 9. List of Global Tier 1 Nanomaterials in Personalized Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Nanomaterials in Personalized Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Nanomaterials in Personalized Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Nanomaterials in Personalized Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Nanomaterials in Personalized Medicine Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Nanomaterials in Personalized Medicine Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Nanomaterials in Personalized Medicine Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Nanomaterials in Personalized Medicine Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Nanomaterials in Personalized Medicine Product Offerings
    Table 32. Abbott Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Nanomaterials in Personalized Medicine Product Offerings
    Table 35. Amgen Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 36. Biogen Corporate Summary
    Table 37. Biogen Nanomaterials in Personalized Medicine Product Offerings
    Table 38. Biogen Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 39. Celgene Corporate Summary
    Table 40. Celgene Nanomaterials in Personalized Medicine Product Offerings
    Table 41. Celgene Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 42. Gilead Sciences Corporate Summary
    Table 43. Gilead Sciences Nanomaterials in Personalized Medicine Product Offerings
    Table 44. Gilead Sciences Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 45. Merck and Co Corporate Summary
    Table 46. Merck and Co Nanomaterials in Personalized Medicine Product Offerings
    Table 47. Merck and Co Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer Corporate Summary
    Table 49. Pfizer Nanomaterials in Personalized Medicine Product Offerings
    Table 50. Pfizer Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 51. Roche Corporate Summary
    Table 52. Roche Nanomaterials in Personalized Medicine Product Offerings
    Table 53. Roche Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 54. Sanofi Corporate Summary
    Table 55. Sanofi Nanomaterials in Personalized Medicine Product Offerings
    Table 56. Sanofi Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 57. Stryker Corporate Summary
    Table 58. Stryker Nanomaterials in Personalized Medicine Product Offerings
    Table 59. Stryker Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
    Table 60. Teva Pharmaceuticals Corporate Summary
    Table 61. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Product Offerings
    Table 62. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Nanomaterials in Personalized Medicine Segment by Type in 2021
    Figure 2. Nanomaterials in Personalized Medicine Segment by Application in 2021
    Figure 3. Global Nanomaterials in Personalized Medicine Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Nanomaterials in Personalized Medicine Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Nanomaterials in Personalized Medicine Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Nanomaterials in Personalized Medicine Revenue in 2021
    Figure 8. By Type - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 12. US Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 16. Germany Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 17. France Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 24. China Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 28. India Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 30. Brazil Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Nanomaterials in Personalized Medicine Revenue Market Share, 2017-2028
    Figure 33. Turkey Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Nanomaterials in Personalized Medicine Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Biogen Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Celgene Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Gilead Sciences Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck and Co Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Roche Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sanofi Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Stryker Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Nanomaterials in Personalized Medicine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nanomaterials in Personalized Medicine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nanomaterials in Personalized Medicine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ethyl Oxalate Market

Ethyl Oxalate was synthesized by esterification of anhydrous oxalic acid and ethanol in the prese ... Read More